cell therapy

Bristol Myers culls cell therapy deals with 2 biotechs

BMS has terminated cell therapy pacts with two biotechs amid "portfolio prioritization efforts” within the pharma, one of the affected companies said.

Gabrielle Masson Dec 16, 2024 11:19am

A series of dice with a bag on them illustrating cost cuts

Carisma axes sole clinical candidate, lays off 34% of staff

Dec 9, 2024 10:58am

Protara shares spike after bladder cancer data drop

Dec 5, 2024 2:30pm

Group of scientist or doctors and nurses wearing blue protective gloves putting their hands together

Novartis taps Vyriad’s viral vectors for in vivo T cell editing

Nov 20, 2024 12:00pm

Adaptimmune's cell therapy hits key goal in pivotal sarcoma test

Nov 13, 2024 2:57pm

MD Anderson launches cell therapy institute with $80M

Nov 11, 2024 4:20pm